Measles immunization — all countries

Measles immunization — North Macedonia

Measles immunization in North Macedonia in 2024 — 73%. Ranked 158 in the world out of 192. Since 1993, the indicator has fallen by 25 pp.

2024 73% +0 pp vs 2023
World rank 158of 192
Period maximum 98%1993
Period minimum 63%2020

Trend over time

1993–2024 · % of children aged 12–23 months

Measles immunization — North Macedonia, 1993–2024607080901001993199720012005200920132017202120241993: 98%1994: 88%1995: 97%1996: 91%1997: 98%1998: 96%1999: 98%2000: 97%2001: 92%2002: 98%2003: 96%2004: 96%2005: 96%2006: 94%2007: 96%2008: 98%2009: 96%2010: 98%2011: 97%2012: 96%2013: 96%2014: 93%2015: 89%2016: 82%2017: 83%2018: 75%2019: 75%2020: 63%2021: 70%2022: 71%2023: 73%2024: 73%
Change over the period: −25 pp Annual average: -0.81 pp

Comparison, 2024

How the value compares with the world and the groups this territory belongs to: North Macedonia

North Macedonia 73%
World 84.3%
Southern Europe computed 93.7%
Measles immunization — North Macedonia, by year North Macedonia All countries CSV XLSX
Year % Change, pp
2024 73 +0 pp
2023 73 +2 pp
2022 71 +1 pp
2021 70 +7 pp
2020 63 −12 pp
2019 75 +0 pp
2018 75 −8 pp
2017 83 +1 pp
2016 82 −7 pp
2015 89 −4 pp
2014 93 −3 pp
2013 96 +0 pp
2012 96 −1 pp
2011 97 −1 pp
2010 98 +2 pp
2009 96 −2 pp
2008 98 +2 pp
2007 96 +2 pp
2006 94 −2 pp
2005 96 +0 pp
2004 96 +0 pp
2003 96 −2 pp
2002 98 +6 pp
2001 92 −5 pp
2000 97 −1 pp
1999 98 +2 pp
1998 96 −2 pp
1997 98 +7 pp
1996 91 −6 pp
1995 97 +9 pp
1994 88 −10 pp
1993 98

About the indicator

The share of children aged 12–23 months who have been vaccinated against measles. Measles is more contagious than almost any other infection, and its threshold of herd immunity is higher than the rest — about 95% — so a fall in coverage by a few points brings outbreaks back to countries where the disease was considered beaten. This series shows how coverage sagged in 2020–2021 and where it has not recovered since.

Important: The first dose. Reliable protection requires two, and coverage of the second dose is lower; the World Bank has no separate series for it.

Source: Global Health Observatory (WHO), license CC BY-NC-SA 3.0 IGO.